107 related articles for article (PubMed ID: 4016825)
1. Possible involvement of epinephrine in the cardiovascular effect of naloxone in humans.
Hernandez J; Pérez-Ojeda E; Serrano JS; Castillo JR; Serrano MI
Clin Ther; 1985; 7(4):418-23. PubMed ID: 4016825
[TBL] [Abstract][Full Text] [Related]
2. Effect of an opiate antagonist (naloxone) and an agonist/antagonist (nalbuphine) in primate hemorrhagic shock: relationship to catecholamine release.
McIntosh TK; Palter M; Grasberger R; Vezina R; Yeston NS; Egdahl RH
Circ Shock; 1985; 17(4):313-25. PubMed ID: 4092345
[TBL] [Abstract][Full Text] [Related]
3. Effect of intermediate-dose naloxone on cardiovascular and sympathoneural adjustments to exercise.
Floras JS
Clin Invest Med; 1991 Oct; 14(5):409-18. PubMed ID: 1742919
[TBL] [Abstract][Full Text] [Related]
4. Endogenous opiate peptides may limit norepinephrine release during hemorrhage.
Schadt JC; Gaddis RR
J Pharmacol Exp Ther; 1985 Mar; 232(3):656-60. PubMed ID: 3973823
[TBL] [Abstract][Full Text] [Related]
5. Naloxone potentiates the cardiovascular effects of catecholamines in canine hemorrhagic shock.
Lechner RB; Gurll NJ; Reynolds DG
Circ Shock; 1985; 16(4):347-61. PubMed ID: 3836027
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.
Sardina M; Warrington SJ; Boyce M; Johnston A; Bianchini C
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S80-90. PubMed ID: 8839231
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic and catecholamine changes after administration of naloxone.
Estilo AE; Cottrell JE
Anesth Analg; 1982 Apr; 61(4):349-53. PubMed ID: 7199852
[TBL] [Abstract][Full Text] [Related]
8. Naloxone potentiates epinephrine's pressor actions in endotoxemic rats.
Malcolm DS; Zaloga GP; Willey SC; Amir S; Holaday JW
Circ Shock; 1988 Aug; 25(4):259-65. PubMed ID: 3048771
[TBL] [Abstract][Full Text] [Related]
9. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
Leenen FH; Davies RA; Fourney A
Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
[TBL] [Abstract][Full Text] [Related]
10. Alpha-adrenoceptor blockade by tibalosine: hemodynamic and humoral effects at rest and during exercise, and effect of opioid receptor antagonism.
Staessen J; Fiocchi R; Fagard R; Lijnen P; Amery A
J Cardiovasc Pharmacol; 1986; 8(5):1028-34. PubMed ID: 2429076
[TBL] [Abstract][Full Text] [Related]
11. The role of endogenous opioids in mediating pain reduction by orally administered glucose among newborns.
Gradin M; Schollin J
Pediatrics; 2005 Apr; 115(4):1004-7. PubMed ID: 15805377
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of acute haemodynamic response to high-dose naloxone in young hypertensive and normotensive humans.
Hara K; Senn BM; Floras JS
Clin Invest Med; 1995 Apr; 18(2):108-13. PubMed ID: 7788955
[TBL] [Abstract][Full Text] [Related]
13. Possible role of an endogenous opioid in the antihypertensive action of propranolol in spontaneously hypertensive rats.
Farsang C; Ramirez-Gonzalez MD; Tchakarov L; Kunos G
Acta Physiol Hung; 1983; 62(2):167-75. PubMed ID: 6670566
[TBL] [Abstract][Full Text] [Related]
14. Neonatal adaptation: naloxone increases the catecholamine surge at birth.
Padbury JF; Agata Y; Polk DH; Wang DL; Callegari CC
Pediatr Res; 1987 Jun; 21(6):590-3. PubMed ID: 3037473
[TBL] [Abstract][Full Text] [Related]
15. Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers.
Sardina M; Love R; Mizrahi J; Monzani V; Bianchini C
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S72-9. PubMed ID: 8839230
[TBL] [Abstract][Full Text] [Related]
16. The role of endogenous opioids in thermoregulation during sub-maximal exercise.
Schwellnus MP; Gordon NF
Med Sci Sports Exerc; 1987 Dec; 19(6):575-8. PubMed ID: 2828818
[TBL] [Abstract][Full Text] [Related]
17. Failure of naloxone to reduce clonidine-induced changes in blood pressure, heart rate and sympathetic nerve firing in cats.
Shropshire AT; Wendt RL
J Pharmacol Exp Ther; 1983 Mar; 224(3):494-500. PubMed ID: 6827474
[TBL] [Abstract][Full Text] [Related]
18. Effect of eprosartan on catecholamines and peripheral haemodynamics in subjects with insulin-induced hypoglycaemia.
Christensen M; Ibsen H; Worck R
Clin Sci (Lond); 2005 Feb; 108(2):113-9. PubMed ID: 15383007
[TBL] [Abstract][Full Text] [Related]
19. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
Freye E; Neruda B; Smith OW
Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
[TBL] [Abstract][Full Text] [Related]
20. Naloxone reversal of hypovolemic shock in dogs.
Vargish T; Reynolds DG; Gurll NJ; Lechner RB; Holaday JW; Faden AI
Circ Shock; 1980; 7(1):31-8. PubMed ID: 6248264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
